Who We Are

Cynvec is an innovative biotechnology company that specializes in developing viral immunotherapies. We are developing a proprietary experimental cancer therapy based on the Sindbis oncolytic viral vector, a new treatment platform for cancer patients that naturally uses the subject’s own immune system to fight infection. Administered by a simple injection, this novel approach to cancer treatment targets the tumor as the therapeutic is effectively distributed throughout the body.